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Abstract
Protein 4.1 is an - 80-kD structural protein in the membrane
skeleton which underlies and supports the erythrocyte plasma
membrane. The preceding companion paper presents a bio-
chemical study of two abnormal protein 4.1 species from indi-
viduals with the red blood cell disorder, hereditary elliptocy-
tosis. These variants, "protein 4.168/65" and "protein 4.195,
have altered molecular weights due to internal deletions and
duplications apparently localized around the spectrin-actin
binding domain. Here we use polymerase chain reaction (PCR)
techniques to clone and sequence the corresponding mutant
reticulocyte mRNAs, and correlate the deletion/duplication
end points with exon boundaries of the gene. Protein 4.*68/65
mRNA lacks sequences encoding the functionally important
spectrin-actin binding domain due to a 240 nucleotide (nt) de-
letion spanning the codons for Lys`7-Gly46. Protein 4.195
mRNA encodes a protein with two spectrin-actin binding do-
mains by virtue of a 369 nt duplication of codons for Lys7-
Gln529. These deletions and duplications correspond to gene
rearrangements involving three exons encoding 21, 59, and 43
amino acids, respectively. The duplicated 21 amino acid exon
in the 4.195 gene retains its proper tissue-specific expression
pattern, being spliced into reticulocyte 4.1 mRNA and out of
lymphocyte 4.1 mRNA. (J. Clin. Invest. 1990. 86:524-530.)
Key words: erythrocyte - protein 4.1 * mutations * gene rear-
rangements PCR
Introduction
Protein 4.1 is a structural protein of 78-80 kD localized to the
erythroid membrane skeleton that underlies the red cell
plasma membrane. Protein 4.1 plays a critical role in regu-
lating the mechanical properties of the erythrocyte membrane
through multiple interactions with integral membrane pro-
teins (band 3 and glycophorin C), with a membrane skeletal
protein (spectrin), and with a cytoskeletal protein (actin). Ge-
netic and biochemical evidence (1-3) clearly implicate muta-
tions in protein 4.1 in the etiology of some cases of hereditary
elliptocytosis (HE), I which vary from mild to severe hemolytic
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1. Abbreviations used in this paper: aa, amino acid(s); HE, hereditary
elliptocytosis; nt, nucleotide; PCR, polymerase chain reaction.
anemia. Chromosome mapping studies have localized the
human protein 4.1 gene to a site near the Rh locus that has
been closely linked to HE (lp32 -) pter, references 3-5). In
addition, quantitative deficiencies (1, 2) or qualitative defects
(4) in protein 4.1 have been found to co-segregate with the HE
phenotype in at least four families, and restriction fragment
length polymorphisms were linked to HE and partial 4.1 defi-
ciency in another family (6).
In this report and the preceding companion paper (7), two
novel structural variants of protein 4.1 are characterized. Both
polypeptides are distinguished by aberrant electrophoretic
mobilities on SDS-polyacrylamide gels, i.e., different from the
normal apparent molecular weight of 78-80 kD (protein
4. l80). Based on biochemical analysis in the preceding paper,
both also have structural alterations in the functionally im-
portant spectrin-actin binding domain. One is a low molecular
weight variant (protein 4.168/65) that in heterozygotes causes
elliptocytosis and moderately severe hemolysis. Chemical and
enzymatic cleavage patterns, as well as immunologic data, re-
vealed a deletion of part or all of the spectrin-acting binding
domain in protein 4. 168/65. The second variant has a high mo-
lecular weight (protein 4. 19), which in heterozygotes produces
only mild elliptocytosis without anemia. Structural analysis of
protein 4.195 revealed an insertion of 15 kD adjacent to the
spectrin-actin binding domain, and partial amino acid se-
quence data suggested a duplication of 57 amino acids (aa) of
the 24-kD chymotryptic domain comprised part of the 1 5-kD
insert.
In this paper we report cloning and sequencing of reticulo-
cyte mRNA sequences encoding portions of proteins 4.168/65
and 4.195, using reverse transcriptase and polymerase chain
reaction (PCR) techniques (8) to amplify the likely rearranged
regions as identified by the protein studies. This molecular
characterization allowed us to deduce the primary structure of
the abnormal 4.1 polypeptides. In addition, by comparison of
the deletion and duplication end points in these mutant pro-
teins with known exon-exon boundaries in that part of the
protein 4.1 gene, we could deduce as well the genetic origin of
these rearrangements. Finally, by comparing 4.195 mRNA
from reticulocytes vs lymphocytes, we were able to examine
the effects of a gene rearrangement on splicing of an alterna-
tively expressed exon of 21 amino acids in the spectrin-actin
binding region.
Methods
Reagents. [32P]dCTP and [32P]yATP were obtained from Amersham
Corp. (Arlington Heights, IL). Reverse transcriptase was supplied by
Molecular Genetics Resources (Tampa, FL), RNasin by Promega Bio-
tech (Madison, WI), Taq. polymerase by Perkin Elmer Cetus Corp.
(Norwalk, CT), and restriction endonucleases by New England Biolabs
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(Beverly, MA). The plasmid vector Bluescript was purchased- from
Stratagene (San Diego, CA), and M13mpl8 DNA from Pharmacia
Fine Chemicals (Piscataway, NJ).
RNA isolation. Human reticulocyte mRNA was prepared as de-
scribed previously (9) from blood of patients with elliptocytosis due to
mutant protein 4.1. For normal protein 4.1 controls, reticulocyte
mRNA was prepared from blood of sickle cell anemia patients under-
going exchange transfusion.
PCR amplification ofprotein 4.1 mRNAfrom reticulocytes. 1 Mg of
human reticulocyte poly (A)+ RNA was transcribed into single-
stranded DNA at 420C for 60 min in a 20-Mil reaction containing: 40
mM KCI, 50 mM Tris-HCl (pH 8.3), 8 mM MgCl2, 0.5 mM dNTPs,
50 pmol of antisense 4.1-specific oligonucleotide primer (see below),
20 U ofAMV reverse transcriptase, and 10 U of RNasin. The reaction
was diluted to 100 Ml in Taq. polymerase buffer (50 mM KC1, 10 mM
Tris-HCI, 1.5 mM MgCl2, 0.1% gelatin) supplemented with 50 pmol of
sense-strand oligonucleotide, additional dNTPs to a final concentra-
tion of0.2 mM, and 5 U ofTaq. polymerase. 30 cycles ofamplification
were performed using an automated Perkin Elmer Cetus thermal
cycler under the following conditions: denaturation 30' at 94°C; rean-
nealing, 30" at 50-65°C; extension, 1'45" at 72°C. DNA fragments
were analyzed by polyacrylamide gel electrophoresis. For sequencing,
fragments were phosphorylated using polynucleotide kinase, blunt-end
ligated into the Eco RV site ofBluescript and sequenced directly in the
double-stranded plasmid. The oligonucleotides used in this paper are
shown in Table I.
Results
Deduced structure ofprotein 4.19" in reticulocytes. Normal
protein 4.180 consists of four structural domains of apparent
molecular weights of 30, 16, 10, and 24 kD (10). In the preced-
ing paper (7), biochemical analysis of these domains in the
elongated variant protein 4.19 revealed an insertion in the
10-kD spectrin-acting binding domain between Lys406 and
Lysg7, which are the first two residues of this domain, and a
known exon boundary. Partial amino acid sequence data sug-
gested that the insert represents an internal duplication of at
least 57 amino acids from Arg473-Gln529 in the 24 kD domain
(7) (Fig. 1 A). In order to characterize further this unusual
structural variant, 4.19S mRNA sequences were cloned and
analyzed using 4. 1-specific oligonucleotides (Table I) and PCR
methodologies. Fig. 1 B presents the PCR strategy employed,
depicting the map location ofthe expected amplification prod-
ucts relative to the structural domains ofthe protein, while Fig.
1 C shows a polyacrylamide gel analysis of the observed DNA
bands produced in each reaction. Although the affected HE
individuals are heterozygous for 4.180 mRNA and 4.195
mRNA, it was possible by judicious choice of oligonucleotides
to preferentially amplify 4.19" mRNA. Reaction I was designed
to confirm the protein data suggesting that 24-kD sequences
were inserted upstream of Lys"7, by using oligonucleotide
primers flanking the putative 24-kD/10-kD junction to am-
plify the COOH-terminal end of the insert. No product was
expected or observed when normal reticulocyte mRNA was
used as a template, since the 5' and 3' primers are oriented
away from each other (reaction Ta). However, due to the ab-
normal transposition of 24-kD sequences upstream of 10-kD
sequences in 4.19" mRNA, these oligonucleotides are oriented
toward each other at the junction and can amplify a band of
130 bp. A band of appropriate size was indeed obtained from
4.19i mRNA (reaction lb). Sequence analysis of this DNA
fragment confirmed that 4.195 mRNA contains an insertion of
24-kD coding sequences upstream of Lys"7 in the spectrin-
actin binding domain.
Protein 4.195 mRNA sequences encompassing the entire
15-kD insert were cloned next using a 5' oligonucleotide lo-
cated upstream in the 16 kD domain and a 3' oligonucleotide
precisely positioned at the 24-kD/ 10-kD junction at the 3' end
of the insert. Since the 3' primer is derived from sequences in
24 kD and 10 kD that are discontinuous in 4.18° mRNA, no
product was obtained when normal reticulocyte mRNA was
amplified (reaction Ila). However, a DNA band of 587 bp was
obtained from 4.19" mRNA (reaction Ilb). Sequence analysis
of this DNA revealed normal coding sequences in the 16-kD
region up to residue Lys4e7 at the start of 10 kD, followed by an
insert of 123 amino acids representing a duplication of an
almost intact 10-kD region (Lys407-Trp472) plus residues
Arg473-Gln529 of 24 kD predicted from the protein studies.
The region of 4.195 mRNA 3' to the insert was cloned using
oligonucleotide primers depicted in reaction ITl. Since the 5'
oligonucleotide is present within the duplicated portion of 24
kD and the 3' primer is located in a downstream nondupli-
cated portionof 24 kD, two amplification products are possible
using the 4.195 mRNA template (reaction IIIb). Upon se-
quencing, the larger 502 bp band revealed the COOH-terminal
end of the insert (i.e., the 24-kD/10-kD junction), followed by
a normal 10-kD and 24-kD sequence. Normal 4.1° mRNA
possesses only one copy of the 5' primer and thus yields only a
single 1 33-bp band (reaction IIa).
Table . Sequences ofOligonucleotides Usedfor PCR Amplification ofProtein 4.1 mRNA









IX 5'GCTGTCGATTCGGCAGACCGAAGTCCTCGGCCC-3' Y-CTrfTTCTCT rrr-T-l-l-CTGGGC-3'
X 5'-AATCCCAACCAAAGACGT-3' 5'-CTCAGATGTGATAGTTTG-3'
Note that the same 5' primer was used in reactions II, VI and IX; also in reactions I, III, and X. The same 3' primer was used in reactions II
and IX. These sequence data are available from GenBank under accession number M14993.
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Figure 1. Scheme for 4.195 mRNA analysis by PCR. (A) Structural model of 4.195 mRNA. Narrow lines indicate 5' and 3' untranslated regions;
open boxes indicate regions encoding the four structural domains of normal protein 4.180; black box shows the l5-kD insert between Lys' and
Lys4'", as deduced from protein studies. Apparent duplication of Arg473-Gln529 from the 24-kD domain is indicated. (B) Amplified regions of
4. 19 mRNA. Black arrowheads indicate the location of oligonucleotides unique to the insert in 4. 195 mRNA but not found in normal 4.18
mRNA; open arrowheads represent primers present in both 4.180 and 4.195 mRNAs. Reactions I-III analyze the 15-kD insert and its flanking
sequence. Reactions IV-VII complete the characterization of upstream and downstream portions of 4.195 mRNA. The notation "a" refers to
4.180 mRNA and "b" indicates 4.195 mRNA. (C) 5% polyacrylamide gel electrophoresis of amplified DNA products. Black arrows indicate the
bands unique to 4.195 mRNA.
Finally, amplification of sequences encoding the 30- and
16-kD domains, as well as the COOH-terminal end of 24 kD
and parts of the 5' and 3' untranslated sequence, was accom-
plished using additional oligonucleotides (reactions IV-VII).
All of these regions yielded PCR products that were indistin-
guishable in size from those obtained with normal 4.180
mRNA substrates (compare lanes a and b in Fig. 1 C), sug-
gesting that there are no other abnormalities or rearrange-
ments present in 4. 195 mRNA.
Structure ofprotein 4. 15/68. A tentative structural model of
the shortened protein 4.165/68 polypeptide, based on protein
analyses in the preceding paper (7), is shown in Fig. 2 A. To
deduce the precise limits of the apparent deletion around the
spectrin-acting binding region, the coding region of 4.165/68
mRNA was amplified in a series of seven PCR reactions using
4.1-specific oligonucleotides. In each reaction, reticulocyte
RNA from an individual with normal protein 4.1 was used as a
control for comparison with the heterozygous HE patient. Re-
actions IV-VII yielded identical amplified DNAs in the nor-
mal and HE samples, indicating the absence ofgross structural
abnormalities in the 30-kD, 16-kD, and extreme COOH-ter-
minal coding regions of 4.165/68 mRNA. In contrast, the ap-
pearance of a unique shortened DNA band in reaction VIIb
(Fig. 2 C, arrowhead), in addition to the normal 539bp band



























Figure 2. Scheme for 4.16s/68 mRNA analysis by PCR. (A) Structural model of 4.165/68 mRNA. Narrow lines indicate 5' and 3' untranslated re-
gions; open boxes indicate regions encoding the four structural domains of normal protein 4.18; brackets encompass region of possible deletion
deduced from the protein studies. (B) Amplified regions of 4.165/68 mRNA. Arrowheads indicate the oligonucleotide primer locations. Reac-
tions VIII reveal a deletion in 4. 165/68 mRNA (dotted line in VIIb) not seen in 4.18° mRNA (solid line, VIlla). The notation "a" refers to 4.18°
mRNA and "b" indicates 4.165/68 mRNA. (C) 5% polyacrylamide gel electrophoresis of amplified DNA products. Black arrowhead indicates
the band unique to 4.165/68 mRNA.
(reaction Villa), reveals an abnormality in the 10-kD coding
sequence. Nucleotide sequence analysis ofthe shortened DNA
band defined a 240 nt deletion in 4.165/68 mRNA that would
encode a protein with a deletion of 80 aa from Lysg7-Gly486.
Included within this deletion is the entire 67-amino acid spec-
trin-actin binding domain (except for the first residue Lys")
and a portion of the COOH-terminal 24-kD domain.
Genetic basis for protein 4.1 structural rearrangements.
The deduced structures of proteins 4.165/68 and 4.19" contain
internal deletions and duplications of peptides within the same
small region of the protein 4.1 polypeptide, the functionally
important spectrin-actin binding domain. To determine how
these rearrangements in protein structure relate to 4.1 gene
alterations, we compared the end points of these peptides to
the deduced exon boundaries in this part of the gene. As de-
scribed below and illustrated in Fig. 3, this comparison indi-
cates that 4.168/65 mRNA suffers a two-exon deletion, while
4. 19" mRNA possesses a three-exon duplication.
Exon boundaries in the spectrin-actin binding and 24-kD
coding sequences have been deduced mainly through studies
of alternative RNA splicing in normal protein 4.18° mRNA
(1 1). Multiple structural isoforms of erythroid 4.1 mRNA,
characterized by insertion or deletion of nucleotide sequence
cassettes corresponding to individual exons, arise by an alter-
native splicing mechanism (1 1, 12). Two of these alternatively
expressed exons encode peptides Lys'""-Gu421 (21 aa) and
Pro487-Gln529 (43 aa), located exactly at the end points of the
rearrangements in 4.195 mRNA and 4.168/65 mRNA (Fig. 3).
To test whether the intervening 59 aa peptide Asp428-Gly486 is
encoded by a single exon, genomic DNA was amplified using
oligonucleotides spanning this coding region. A single band of
177 nt was produced, indicating that this sequence is not in-
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Figure 3. Genetic models of 4.18°, 4.195, and 4.165/68. (A) Structure of protein 4. l80 and partial gene map of the normal 4.180 gene. The size and
boundaries of four consecutive exons has been deduced by analysis of alternatively spliced 4.1 mRNA isoforms (1 1), by PCR amplification of
genomic DNA (unpublished), and by sequencing of genomic DNA (in the case of the 34 amino acid exon). Boxes represent exons; numbers
above each box indicate the amino acids encoded by that exon (reference 13, with the insertion of 34 aa, residues 530-563, that were not en-
coded in the original clone). Expression of the three exons encoding Lysg47-1n529 is altered in protein4.19and protein 4.165/68. B. Structure of
protein 4.195 and proposed map of the 4.195 gene. The duplicated sequence of Lysg7-Gln51 is proposed to be encoded by a duplication of three
consecutive exons in the 4.1 gene. (C) Structure of protein 4.165168 and proposed map of the 4.165/68 gene. The two shaded exons within the
brackets are not represented in the shortened protein product.
terrupted by any introns and is thus a single exon (data not
shown).
Alignment of the exon map with the domain map for pro-
tein-4.1 reveals that the 123-aa insertion in protein 4. I" cor-
responds exactly to a duplication of three consecutive exons
encoding 21, 59, and 43 aa (Fig. 3 B). Similarly, the 80-aa
deletion in protein 4.168/65 is due to deletion from the mRNA
of only the first two of these exons (21 and 59 aa; Fig. 3 C).
Deduced structure ofprotein 4. 19 in lymphocytes. Compar-
ison of erythroid (13) and lymphocyte (12) protein 4.1 cDNAs
has revealed a tissue-specific splicing difference involving al-
ternative splicing of the 21-aa exon. Most erythroid 4.1 iso-
forms express this 21 aa in their spectrin-actin binding do-
main, while the predominant lymphoid isoforms lack this
peptide. In the 4.195 gene, two copies of the 21-aa exon are
present. The 5' copy is apparently flanked by normal 5' and 3'
neighboring exons, so its splicing behavior should be normal.
The 3' copy of this 21 aa exon, on the other hand, is flanked by
a different 5' exon than is usual. Its splicing pattern might be
disrupted by this rearrangement.
To explore the alternative splicing of protein 4.195 mRNA
in lymphocytes, RNA was isolated from PHA-stimulated pe-
ripheral blood lymphocytes from an individual with 4.195.
Lymphocyte 4.19" mRNA was amplified with the oligonucleo-
tides indicated in Fig. 4. Reaction IX spanned the 5' copy of
the 21 -aa exon while reaction X encompassed sequences
around the 3' copy. In each reaction the predominant lym-
phoid product (lane b) was slightly smaller than the corre-
sponding reticulocyte band (lane a). Sequence analysis showed
that reticulocyte 4.195 mRNA expressed both copies of the 21
aa exon, while the predominant lymphoid 4.195 mRNA had
both copies of this exon spliced out.
Discussion
We have characterized two interesting structural variants of
erythroid protein 4.1 by direct analysis of the mutant polypep-
tides (7) and by molecular cloning of mutant mRNA se-
quences using PCR techniques (this report). In the case of
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Figure 4. PCR analysis of splicing in reticulocyte and lymphocyte 4. 1" spectrin-actin binding domains. (A) Deduced structure ofthe coding re-
gion of 4. 1"s mRNA in reticulocytes. Each of the two duplicated l0-kD domains contains a 21 aa peptide encoded by a 63 nt exon that is nor-
mally spliced out of lymphocyte 4.180 mRNA (12). (B) Arrowheads show the location of oligonucleotides used to amplify separately the I0-kD
domains in 4. 1"1 mRNA. Lines indicate deduced structures of the predominant mRNA isoforms produced from reticulocyte vs lymphocyte
4.1"s mRNA. The notation "a" refers to reticulocyte 4.19 mRNA and "b" indicates lymphocyte 4.195 mRNA. (C) Ethidium bromide stained
5% polyacrylamide gel electrophoresis ofPCR products.
protein 4.168/65, ektacytometric data showed that red cells from
heterozygous patients expressing normal and shortened 4.1
exhibit mechanical properties similar to those from patients
with 50% deficiency of 4.1, i.e., both have decreased fragmen-
tation times. It is now clear that this phenotype results from an
80-aa deletion that removes the functionally important spec-
trin-actin binding domain. Protein 4. 195, on the other hand, is
elongated by virtue of a 123-aa duplication that results in ex-
pression of two spectrin-actin binding regions. At least one of
these domains must remain in a functional conformation,
since 4.180+95 red cells are mechanically similar to normal cells.
The genetic mechanism(s) responsible for production of
proteins with large internal structural rearrangements is of
great interest. Probably the best documented mechanism for
producing gene deletions and insertions is unequal crossing
over between repetitive sequence elements in the DNA. For
example, unequal crossing over between repeated sequences in
the fl-globin gene cluster produced reciprocal deletions and
insertions manifested as unusual hybrid globin chains 6ft (Le-
pore) and (Tb (anti-Lepore) (14). While these globin rearrange-
ments occurred over distances of - 7 kb and involved sepa-
rate genes, similar phenomena can occur within the confines
of a single gene. Crossing over between 3.4-kb repeated se-
quences in the glycophorin C can delete either exon 2 (15) or
exon 3 (16), producing shortened protein variants. Likewise,
an internal duplication of 373 aa in a mutant LDL receptor
has been attributed to unequal crossing over between middle
repetitive Alu sequences in introns 1 and 8, duplicating 14 kb
of the gene including exons 2-8 (17).
Our results show that sequences from two exons are miss-
ing from protein 4.168/65, while three are duplicated within
protein 4.19. By analogy with the examples cited above, these
findings probably reflect gene rearrangements produced by un-
equal crossing over. The size ofthese putative duplications and
deletions in the protein 4.1 gene are probably > 10 kb, based
on preliminary Southern blotting and genomic cloning exper-
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iments (not shown). Both putative 4.1 gene rearrangements
occur in the same region of the gene; however, they cannot
represent reciprocal products of a single crossing over event,
since they possess distinct 3' boundaries. Rather, it may be that
this portion of the protein 4.1 gene is a hot spot for such
recombination events. Previous analyses of numerous dele-
tions in the Duchenne muscular dystrophy gene have demon-
strated precedence for recombination hot spots (18-20).
One functional contrast exists between the LDL receptor
mutant and 4.195. Whereas the elongated LDL receptor is
functionally defective, protein 4.195 apparently retains its abil-
ity to interact with other membrane skeletal elements, based
on ektacytometric data showing that 4.180/4.195 cells have
nearly normal mechanical properties (7). It is interesting to
speculate on the evolutionary possibilities of such a protein
with a duplicated functional region. This unusual protein 4.195
might be in an advantageous situation in which to evolve new
binding interactions or new mechanisms to regulate existing
interactions, since alterations in one domain would still leave
one functional domain intact. Gene duplication and diver-
gence events are known to play a major role in evolution;
many genes, including even the erythroid membrane skeletal
proteins spectrin (21) and ankyrin (22), contain imperfect re-
peats indicative of past duplication events.
The putative duplication in the 4.195 gene has ramifica-
tions with respect to splicing of the resulting pre-mRNA. The
2 l-aa exon is known to be differentially spliced in a tissue-spe-
cific pattern such that it is expressed in erythroid cells but not
in lymphocytes ( 13, 12). The availability of both reticulocyte
and lymphocyte 4.195 mRNA made it possible to ask whether
this differential expression is maintained for both copies ofthis
exon, since the 3' copy is flanked by a different upstream exon
than is usual. By PCR amplification of this region of the
mRNA it was determined that the 5' and 3' copies ofthe 2 l-aa
exon behave similarly: both are spliced into the predominant
erythroid 4.1 mRNA isoforms and out ofthe most abundant
lymphoid isoforms. This finding implies that the signals for
alternative mRNA processing of the 21-aa exon must be a
function of the sequence in or near this exon itself, indepen-
dent of the neighboring exon(s).
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